David M. Mott

Companies

• NovavaxBoard member Jun 18, 2020 to now¹
• Mersana Therapeutics (United States)Board member Jun 27, 2017 to now²
• Adaptimmune (United Kingdom)Board member Jan 4, 2016 to now³
• Ardelyx (United States)Board member Jun 18, 2014 to now⁴
• Epizyme, Inc.Board member May 30, 2013 to Aug 16, 2022⁵
• Enliven Therapeutics, Inc.Board member Mar 11, 2020 to Jun 3, 2022⁶
• TesaroBoard member Jun 27, 2012 to Jan 22, 2019⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• AUArdelyx (United States) ARDX3,349,655 shares⁸$10.4M at $3.09Jun 16, 2026
• ETEnliven Therapeutics, Inc. ELVN229,224 shares⁹$8.6M at $37.32Jun 3, 2022
• Novavax NVAX79,770 shares¹⁰$1.0M at $12.82Jun 20, 2026
• MTMersana Therapeutics (United States)0 shares¹¹Jan 6, 2026
• EEpizyme, Inc.0 shares¹²Aug 12, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 20, 2026Exercised options 18,880 shares of Novavax¹⁰
• Jun 16, 2026Granted 26,455 shares of Ardelyx (United States)⁸
• Jun 16, 2026Granted 20,282 shares of Ardelyx (United States)⁸
• Feb 20, 2026Bought 333,333 shares at $5.84 of Ardelyx (United States)¹³
• Jan 6, 2026U 383 shares of Mersana Therapeutics (United States)¹¹
• Jan 6, 2026U 23,546 shares of Mersana Therapeutics (United States)¹¹
• Jun 18, 2025Granted 41,551 shares of Ardelyx (United States)¹⁴
• Jun 18, 2025Granted 31,163 shares of Ardelyx (United States)¹⁴
• Jun 16, 2025Bought 200,000 shares at $3.63 of Ardelyx (United States)¹⁵
• Jun 12, 2025Exercised options 10,420 shares of Novavax¹⁶
• Jun 9, 2025Bought 200,000 shares at $3.69 of Ardelyx (United States)¹⁷
• May 15, 2025Bought 100,000 shares at $3.29 of Ardelyx (United States)¹⁸
• May 2, 2025Bought 381,377 shares at $4.22 of Ardelyx (United States)¹⁹
• Feb 24, 2025Bought 77,729 shares at $5.00 of Ardelyx (United States)²⁰
• Jan 21, 2025Bought 199,000 shares at $4.99 of Ardelyx (United States)²¹
• Dec 26, 2024Exercised options 100,000 shares at $0.55 of Ardelyx (United States)²²
• Dec 19, 2024Bought 213,300 shares at $4.67 of Ardelyx (United States)²³
• Nov 13, 2024Bought 215,868 shares at $4.62 of Ardelyx (United States)²⁴
• Jun 14, 2024Granted 17,322 shares of Ardelyx (United States)²⁵
• Jun 12, 2024Exercised options 6,670 shares of Novavax²⁶
• Jan 2, 2024Granted 8,810 shares of Mersana Therapeutics (United States)²⁷
• Oct 2, 2023Granted 15,873 shares of Mersana Therapeutics (United States)²⁸
• Jul 3, 2023Granted 6,079 shares of Mersana Therapeutics (United States)²⁹
• Jun 15, 2023Granted 25,510 shares of Ardelyx (United States)³⁰
• Jun 10, 2023Exercised options 3,100 shares of Novavax³¹